Location History:
- Hovås, SE (2013 - 2014)
- Hovás, SE (2012 - 2015)
- Hovas, SE (1997 - 2018)
Company Filing History:
6 out of 8 
2 out of 9 
1 out of 1 Years Active: 1997-2018
Title: The Innovations of Hans-Arne Hansson
Introduction
Hans-Arne Hansson is a notable inventor based in Hovás, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in optimizing cellular uptake of various substances. With a total of 10 patents to his name, Hansson's work has the potential to impact medical treatments significantly.
Latest Patents
One of Hansson's latest patents focuses on the use of antisecretory factors (AF) for optimizing cellular uptake. This invention relates to the application of an AF protein, peptide, derivative, homologue, and/or fragment that possesses equivalent functional activity. The patent emphasizes the importance of these factors in enhancing the delivery and cellular uptake of pharmaceutical substances or formulations. These substances may include anticancer drugs, radiation therapy, antibiotics, antiviral agents, and drugs targeting various medical conditions such as posttraumatic injuries and neurodegeneration.
Career Highlights
Throughout his career, Hans-Arne Hansson has worked with reputable organizations, including Lantmännen As-faktor AB and the Institute of Molecular Biology, Inc. His experience in these companies has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical science.
Collaborations
Hansson has collaborated with several professionals in his field, including Stefan Lange and Eva Jennische. These partnerships have likely facilitated the exchange of ideas and fostered innovation in his research endeavors.
Conclusion
Hans-Arne Hansson's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work in optimizing cellular uptake has the potential to enhance medical treatments and improve patient outcomes.